Importantly, we report for the first time that inhibition of translation by HHT in CML cells could be reduced in the bone marrow niche, and TIAR protein might play a role in this process. This evidence concerns the gene TIAL1 and chronic myelogenous leukemia, BCR-ABL1 positive.